文献速递泌尿与男性生殖病理细胞病理与分子病理

获得性囊性病相关肾细胞癌的复发性拷贝数模式及其与乳头状肾细胞癌的重叠

Acquired Cystic Disease-Associated Renal Cell Carcinoma: Recurrent Copy-Number Patterns and Overlap With Papillary Renal Cell Carcinoma.
PubMed 文献 · Am J Surg Pathol · 2026-10-23

本研究对13例患者的14个获得性囊性病相关肾细胞癌(ACD-RCC)肿瘤进行靶向二代测序和拷贝数分析,发现单基因改变少见且异质,但拷贝数改变呈现三种模式:以增益为主、以缺失为主和近整倍体。以增益为主的肿瘤与乳头状肾细胞癌(PRCC)在染色体7、16、17和20增益上重叠,且同一患者的ACD-RCC与同步PRCC具有高度相似的臂级拷贝数谱。

要点

  • ACD-RCC拷贝数改变可分为增益为主、缺失为主和近整倍体三种模式。
  • 以增益为主的ACD-RCC与PRCC共享染色体7、16、17和20增益。
  • 同一患者的ACD-RCC与同步PRCC臂级拷贝数谱高度相似。

核心结论

  • ACD-RCC虽基因水平改变异质,但存在复发性臂级染色体改变模式。
  • 以增益为主的ACD-RCC与PRCC存在显著分子重叠,提示基因组相似性。
  • 拷贝数模式可能为理解ACD-RCC异质性提供分子框架。

研究设计与样本

  • 研究对13例患者的14个ACD-RCC肿瘤进行靶向二代测序和拷贝数分析。
  • 所有肿瘤均具有典型组织学特征:实性筛状和囊性生长、丰富嗜酸性胞质。
  • 核仁分级高者占13/14,草酸钙结晶存在于10/14。

主要发现

  • 单基因改变相对少见且异质,队列内无复发性改变。
  • 拷贝数分析显示增益为主组(n=7)、缺失为主组(n=4)和近整倍体组(n=3)。
  • 增益为主组反复出现染色体3、7、16、17和20增益。
  • 缺失为主组反复出现染色体6、9、14、19和21缺失。
  • 近整倍体组染色体拷贝数改变相对较少。

关键数值与推荐

  • 与TCGA-KIRP数据比较,增益为主ACD-RCC与PRCC共享染色体7、16、17和20增益。
  • 同一患者的ACD-RCC与同步PRCC臂级拷贝数谱高度相似,仅ACD-RCC额外有染色体3q增益。
  • 文献回顾中偶尔复现的基因改变包括KMT2C、SETD2、FANCA和FAT1。

临床怎么用

  • 病理科医生可关注ACD-RCC的拷贝数模式,辅助区分其与PRCC。
  • 对于组织学形态不同的ACD-RCC与PRCC,分子重叠提示需结合形态和分子综合诊断。
  • 拷贝数分析可能有助于理解ACD-RCC的异质性。

局限性

  • 样本量较小(13例患者,14个肿瘤)。
  • 单基因改变异质且无复发性,结论受限于队列规模。
  • 文献回顾中复现的基因改变仅为偶尔出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acquired cystic disease-associated renal cell carcinoma (ACD-RCC) is a histologically distinctive renal neoplasm arising in patients with end-stage renal disease, in which the molecular underpinnings remain incompletely characterized. In this study, 14 ACD-RCC tumors from 13 patients underwent comprehensive targeted next-generation sequencing with copy-number analysis. All tumors had classic histologic features characterized by solid sieve-like and cystic growth with abundant eosinophilic cytoplasm, predominantly high nucleolar grade (13/14), and variably present calcium oxalate crystals (10/14). By sequence analysis, single-gene alterations were relatively infrequent and heterogenous, with no recurrent alterations within the cohort; though several alterations identified were occasionally recurrent across studies on literature review (eg, KMT2C, SETD2, FANCA, and FAT1). Copy-number analysis identified 3 patterns of chromosomal alterations: gain-predominant (n=7), loss-predominant (n=4), and near-euploid (n=3) subgroups. Gain-predominant tumors harbored recurrent gains of chromosomes 3, 7, 16, 17, and 20, whereas loss-predominant tumors showed recurrent losses of chromosomes 6, 9, 14, 19, and 21. The near-euploid group had relatively fewer chromosomal copy-number alterations. Notably, comparison with publicly available The Cancer Genome Atlas papillary renal cell carcinoma (PRCC, TCGA-KIRP) data demonstrated overlapping gains of chromosomes 7, 16, 17, and 20 with the gain-predominant ACD-RCC. In addition, a paired ACD-RCC and synchronous PRCC from the same patient in our cohort displayed highly similar arm-level copy-number profiles, differing only by an additional gain of chromosome 3q in the ACD-RCC. In summary, ACD-RCC demonstrates recurrent arm-level chromosomal alteration patterns despite heterogenous gene-level findings. The gain-predominant tumors show substantial molecular overlap with PRCC, supporting genomic similarity between these entities despite distinct histomorphology. Together, these findings also suggest that copy-number patterns may represent a useful molecular framework for understanding heterogeneity within ACD-RCC.

来源:Am J Surg Pathol,查看原文。版权归原作者所有。

引用

  1. Pacheco RR, Sangoi AR, Acosta AM, et al. Acquired Cystic Disease-Associated Renal Cell Carcinoma: Recurrent Copy-Number Patterns and Overlap With Papillary Renal Cell Carcinoma. Am J Surg Pathol. 2026. PMID: 42922082. doi:10.1097/PAS.0000000000002636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。